Blue Trust Inc’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-5,000
Closed -$19.2K – 2687
2026
Q2
$19.2K Hold
5,000
– – ﹤0.01% 1668
2026
Q1
$19.8K Hold
5,000
– – ﹤0.01% 1649
2025
Q4
$33.8K Hold
5,000
– – ﹤0.01% 1490
2025
Q3
$34.9K Hold
5,000
– – ﹤0.01% 1522
2025
Q2
$30.6K Hold
5,000
– – ﹤0.01% 1575
2025
Q1
$38K Hold
5,000
– – ﹤0.01% 1482
2024
Q4
$48.1K Hold
5,000
– – ﹤0.01% 1317
2024
Q3
$34.6K Buy
+5,000
New +$33.1K ﹤0.01% 1718
2024
Q2
– Sell
-5,000
Closed -$38.5K – 2704
2024
Q1
$38.5K Hold
5,000
– – ﹤0.01% 1002
2023
Q4
$36K Hold
5,000
– – ﹤0.01% 1056
2023
Q3
$33K Hold
5,000
– – ﹤0.01% 996
2023
Q2
$17K Hold
5,000
– – ﹤0.01% 1109
2023
Q1
$14K Hold
5,000
– – ﹤0.01% 1502
2022
Q4
$14K Hold
5,000
– – ﹤0.01% 1422
2022
Q3
$17K Buy
+5,000
New +$17.8K ﹤0.01% 1150

Other funds holding MDXG

Blue Trust Inc's MDXG Position: Q3 2026 in Review

Blue Trust Inc sold out of MiMedx Group (MDXG) in Q3 2026, closing a stake of 5,000 shares — an estimated $19.2K sold.

Blue Trust Inc first reported a position in MDXG in Q3 2022 and held it in 15 quarters. The position peaked at $48.1K in Q4 2024. 35 funds tracked by Wall St. Rank hold MDXG as of Q3 2026.

  • Blue Trust Inc reported no remaining MiMedx Group position as of Q3 2026 after selling out during the quarter.
  • Blue Trust Inc sold 5,000 MiMedx Group shares in Q3 2026, an estimated $19.2K.
  • Blue Trust Inc first reported a position in MiMedx Group in Q3 2022 and held it in 15 quarters.
  • Blue Trust Inc's MiMedx Group position peaked at $48.1K in Q4 2024.
  • 35 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2026.

Based on Blue Trust Inc's 13F filing for Q3 2026, filed 15 Oct 2026.